This study was intended to compare the survival rates of two contemporary cohorts of patients with solitary hepatocellular carcinomas 5 4 cm subjected to surgical resection (n = 33) or percutaneous ethanol injection (n = 30). Outcomes in a third cohort, 21 patients with hepatocellular carcinoma who
Percutaneous etharrol injection in the treatment of hepatocellular carcinoma in cirrhosis. A study on 207 patients
β Scribed by Tito Livraghi; Luigi Bolondi; Sergio Lazzaroni; Giuseppe Marin; Alberto Morabito; Gian Ludovico Rapaccini; Andrea Salmi; Guido Torzilli
- Publisher
- John Wiley and Sons
- Year
- 1992
- Tongue
- English
- Weight
- 530 KB
- Volume
- 69
- Category
- Article
- ISSN
- 0008-543X
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
## Background: The long term efficacy of combination therapy with transcatheter arterial embolization (tae) followed by percutaneous ethanol injection (pei) was studied in patients with large primary hepatocellular carcinoma (hcc) tumors and cirrhosis. ## Methods: The series included 83 patients
## Background: Percutaneous ethanol injection (pei) has been used in the far east for treating small, unresectable hepatocellular carcinoma (hcc). to clarify when treatment with pei may be best indicated for western patients with hcc, the authors performed a retrospective analysis of the clinicopat
Transcatheter oily chemoembolization is widely used as palliative therapy for inoperable hepatocellular carcinoma in high-incidence Asiatic areas. To assess its usefulness in the Western form of this cancer, 30 French patients were treated between 1987 and 1990 by intraarterial hepatic injection of
## Abstract ## BACKGROUND The treatment of patients with hepatocellular carcinoma (HCC) presents a major challenge, because associated cirrhosis limits the choice of chemotherapeutic agents. However, the abundant vascularity of HCC presents an attractive target for antiangiogenic therapy that pote